Related Experiment Video
Updated: Jul 16, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
[Pathogenesis of the antiphospholipid syndrome]
Jean-Louis Pasquali1, Vincent Poindron, Anne-Sophie Korganow
1Service de Médecine Interne et Immunologie Clinique, Hôpitaux Universitaires, Strasbourg. jean-louis.pasquali@chru-strasbourg.fr
Presse Medicale (Paris, France : 1983)
|March 28, 2007
Summary
Antiphospholipid syndrome involves autoantibodies causing thrombosis and pregnancy issues. Research suggests these antibodies disrupt natural coagulation, leading to a prothrombotic state and fetal loss in animal models.
Area of Science:
- Immunology
- Hematology
- Reproductive Medicine
Context:
- Antiphospholipid syndrome (APS) is an autoimmune disorder.
- Characterized by recurrent thrombosis and/or pregnancy complications.
- Associated with specific autoantibodies targeting phospholipid-protein complexes.
Purpose:
- To elucidate the pathogenic mechanisms of antiphospholipid syndrome.
- To understand the role of autoantibodies in thrombosis and obstetrical complications.
- To explore the origins and development of pathogenic antiphospholipid antibodies.
Summary:
- APS involves autoantibodies inhibiting natural coagulation regulators, causing a prothrombotic state.
- Animal models demonstrate that human antiphospholipid antibodies induce fetal resorption via complement and neutrophil activation.
- Heparin can inhibit these adverse pregnancy outcomes.
- The origin of these autoantibodies may involve exposure to anionic phospholipids on apoptotic cells, with affinity maturation generating pathogenic forms.
Impact:
- Provides insights into the pathophysiology of antiphospholipid syndrome.
- Highlights the role of autoantibodies in thrombosis and pregnancy loss.
- Suggests potential therapeutic targets for managing APS complications.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...